Decreased expression of S100A6 in oral squamous cell carcinoma

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 479-488

  Yang, Xiao ^a   Wei, Kui Jie ^a   Zhang, Lei ^a   Pan, Hong Ya ^a   Ye, Dong Xia ^a   Zhong, Lai Ping ^a   Zhang, Zhi Yuan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

In vitro cellular carcinogenesis model; Oral squamous cell carcinoma; Proteomics; S100A6

Indexed keywords

CALCYCLIN; MESSENGER RNA; CELL CYCLE PROTEIN; PROTEIN S 100; S100A6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER LOCALIZATION; CANCER PATIENT; CANCER TISSUE; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; AMINO ACID SEQUENCE; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; S100 PROTEINS; VALIDATION STUDIES AS TOPIC;

EID: 77954350301     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000882     Document Type: Article

References (43)

1. Kademani D: Oral cancer. Mayo Clin Proc 82: 878-887, 2007.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Lenaerts K, Bouwman FG, Lamers WH, Renes J and Mariman EC: Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics 8: 91, 2007.
4. Sdek P, Zhang ZY, Cao J, Pan HY, Chen WT and Zheng JW: Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7. Int J Oral Maxillofac Surg 35: 653-657, 2006.
5. Zhong LP, Pan HY, Zhou XJ, et al: Characteristics of a cancerous cell line, HIOEC-B(a)P-96, induced by benzo(a)pyrene from human immortalized oral epithelial cell line. Arch Oral Biol 53: 443-452, 2008.
6. Kuznicki J, Kordowska J, Puzianowska M and Wozniewicz BM: Calcyclin as a marker of human epithelial cells and fibroblasts. Exp Cell Res 200: 425-430, 1992.
7. Filipek A, Puzianowska M, Cieslak B and Kuznicki J: Calcyclin- Ca(2+)-binding protein homologous to glial S-100 beta is present in neurons. Neuroreport 4: 383-386, 1993. (Pubitemid 23116728)
8. Yamashita N, Ilg EC, Schäfer BW, Heizmann CW and Kosaka T: Distribution of a specific calcium-binding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J Comp Neurol 404: 235-257, 1999.
9. Komatsu K, Andoh A, Ishiguro S, et al: Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 6: 172-177, 2000.
10. Alvarez-Chaver P, Rodríguez-Piñeiro AM, Rodríguez- Berrocal FJ, Martínez-Zorzano VS and Páez de la Cadena M: Identification of hydrophobic proteins as biomarker candidates for colorectal cancer. Int J Biochem Cell Biol 39: 529-540, 2007.
11. Yang YQ, Zhang LJ, Dong H, et al: Upregulated expression of S100A6 in human gastric cancer. J Dig Dis 8: 186-193, 2007.
12. Vimalachandran D, Greenhalf W, Thompson C, et al: High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 65: 3218-3225, 2005. (Pubitemid 40524604)
13. Shekouh AR, Thompson CC, Prime W, et al: Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 3: 1988-2001, 2003.
14. Brown LM, Helmke SM, Hunsucker SW, et al: Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog 45: 613-626, 2006.
15. Camby I, Nagy N, Lopes MB, et al: Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 9: 1-19, 1999. (Pubitemid 29056515)
16. Pelc P, Vanmuylder N, Lefranc F, et al: Differential expression of S100 calcium-binding proteins in epidermoid cysts, branchial cysts, craniopharyngiomas and cholesteatomas. Histopathology 42: 387-394, 2003.
17. Luo X, Sharff KA, Chen J, He TC and Luu HH: S100A6 expression and function in human osteosarcoma. Clin Orthop Relat Res 466: 2060-2070, 2008.
18. Calabretta B, Kaczmarek L, Mars W, Ochoa D, Gibson CW, Hirschhorn RR and Baserga R: Cell-cycle-specific genes differentially expressed in human leukemias. Proc Natl Acad Sci USA 82: 4463-4467, 1985.
19. Rehman I, Cross SS, Azzouzi AR, et al: S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 91: 739-744, 2004.
20. Rehman I, Cross SS, Catto JW, et al: Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Prostate 65: 322-330, 2005.
21. Carlsson H, Petersson S and Enerbäck C: Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development. Int J Oncol 27: 1473-1481, 2005.
22. Zhong LP, Chen WT, Zhang CP and Zhang ZY: Increased CK19 expression correlated with pathological differentiation grade and prognosis in oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 377-384, 2007.
23. Zhong LP, Yang X, Zhang L, et al: Overexpression of insulinlike growth factor binding protein 3 in oral squamous cell carcinoma. Oncol Rep 20: 1441-1447, 2008.
24. Sobin LH and Wittekind CH: International Union against cancer (UICC). In: TNM Classification of Malignant Tumours. 6th edition. Wiley-Liss, New York, pp22-26, 2002.
25. Barnes L, Eveson JW, Reichart P and Sidransky D: World Health Organization classification of tumours. In: Pathology and Genetics of Head and Neck Tumours. IARC Press, Lyon, pp168-175, 2005.
26. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔΔCt method. Methods 25: 402-408, 2001.
27. Zhong LP, Wei KJ, Yang X, et al: Increased expression of Annexin A2 in oral squamous cell carcinoma. Arch Oral Biol 54: 17-25, 2009.
28. Turhani D, Krapfenbauer K, Thurnher D, Langen H and Fountoulakis M: Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27: 1417-1423, 2006.
29. He QY, Chen J, Kung HF, Yuen AP and Chiu JF: Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 4: 271-278, 2004.
30. Lo WY, Tsai MH, Tsai Y, et al: Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 376: 101-107, 2007.
31. Koike H, Uzawa K, Nakashima D, et al: Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27: 59-67, 2005.
32. Staab CA, Ceder R, Jägerbrink T, et al: Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res 6: 3705-3717, 2007.
33. Huang X, Wei Y, Li L, et al: Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol 42: 26-31, 2006. (Pubitemid 41831518)
34. Cheng AJ, Chen LC, Chien KY, et al: Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51: 2236-2244, 2005.
35. Murase R, Abe Y, Takeuchi T, et al: Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma. Proteomics Clin Appl 2: 517-527, 2008.
36. Wong DT: Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn 6: 267-272, 2006.
37. Hu S, Yu T, Xie Y, et al: Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4: 55-64, 2007. (Pubitemid 46632026)
38. Park NH, Gujuluva CN, Baek JH, et al: Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene 10: 2145-2153, 1995.
39. Rey O, Baluda MA and Park NH: Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18: 827-831, 1999.
40. Kang MK, Kim RH, Kim SJ, et al: Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer 96: 126-133, 2007.
41. Berta GN, Ghezzo F, D'Avolio A, et al: Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions. J Oral Pathol Med 26: 206-210, 1997. (Pubitemid 27324323)
42. Sapkota D, Bruland O, Bøe OE, Bakeer H, Elgindi OA, Vasstrand EN and Ibrahim SO: Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med 37: 607-615, 2008.
43. Lesniak W, Slomnicki LP and Filipek A: S100A6, new facts and features. Biochem Biophys Res Commun 390: 1087-1092, 2009.